Top Casino Stocks To Buy For 2018

Late last year, Japan legalized casinos in the country, opening up a gaming industry that could generate as much as $30 billion a year in revenues and become the second-largest casino market in the world. As several players scout for licenses, Las Vegas Sands (NYSE: LVS) is ready to invest heavily in the region, committing to an initial investment of $10 billion. While this is a significant number, if Las Vegas Sands is able to capture a decent share in the market, it would make sense given the revenue potential of the market. Currently, Macau and Singapore are the largest value drivers of the company, together accounting for more than 80% of its valuation.

The company is heavily dependent on Macau for revenues, and regulation changes in the region have impacted it negatively. At its peak in 2013, Macau’s gaming market had reached a size of $45 billion. However, after stricter regulations imposed by Chinese regulators, revenues started slumping. In 2016, the total amount won by casinos in the region stood at nearly $28 billion. Japan is likely to emerge as a huge market for casinos, with annual revenue estimates ranging from $10 billion to $30 billion.

Top Casino Stocks To Buy For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

Top Casino Stocks To Buy For 2018: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday.
    General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates.
    Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million.
    South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

Top Casino Stocks To Buy For 2018: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

  • [By SEEKINGALPHA.COM]

    This article is for those who are hopeful of the long-term view and want to get in ahead of time. This article will compare the three front-runners of the Canadian cannabis industry, Canopy Growth Corp. (OTCPK:TWMJF), Aphria (NYSE:APH), and Aurora (OTCQX:ACBFF). Although these companies will soon have to prove themselves in a new environment, there is plenty to study right now. We will be comparing revenue growth, production capacity, valuations, and then making financial projections. The result will be a recommendation of Aurora followed by Canopy. Again this article is meant to compare competitors. The industry has the potential to be a 22.6B industry but the thesis for investing in Canadian cannabis is a separate topic and I encourage you to consider the risks.

  • [By Javier Hasse]

    While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    Todays North Channel Investment article will look at Aurora Cannabis Inc. (OTCQX:ACBFF), and why they could be very appealing to any investor looking for a stock that has great potential for long-term growth.

Top Casino Stocks To Buy For 2018: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Casey Wilson]

    Take general contracting company Tutor Perini (NYSE: TPC), for example.

    The California-based contracting giant is responsible for funding many infrastructure projects, including “Big Bertha,” a huge tunnel-boring project in Seattle, Wash. This tunnel will be 9,270 feet long and 115 feet deep – allowing for a major highway to be carried under downtown Seattle.

Top Casino Stocks To Buy For 2018: Diplomat Pharmacy, Inc.(DPLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

  • [By Paul Ausick]

    Diplomat Pharmacy Inc. (NYSE: DPLO) dropped 7.4% Monday, posting a new 52-week low of $12.25 after closing at $13.23 on Friday. The stock’s 52-week high is $38.94. The specialty pharmacy company said this morning that revenues and adjusted EBITDA for 2016 will come in at or near the low end of the company’s previously announced range.

Top Casino Stocks To Buy For 2018: Vaalco Energy Inc(EGY)

Advisors’ Opinion:

  • [By Monica Gerson]

    VAALCO Energy, Inc. (NYSE: EGY) is expected to post a quarterly loss at $0.11 per share on revenue of $18.59 million.

    B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.

Leave a Reply

Your email address will not be published. Required fields are marked *